Page last updated: 2024-08-17

apomorphine and EHS Tumor

apomorphine has been researched along with EHS Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giridharagopalan, S; Hamamoto, DT; Simone, DA1
von Metzler, A1

Other Studies

2 other study(ies) available for apomorphine and EHS Tumor

ArticleYear
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
    European journal of pharmacology, 2007, Mar-08, Volume: 558, Issue:1-3

    Topics: Animals; Apomorphine; Benzoxazines; Cannabinoid Receptor Agonists; Catalepsy; Cyclohexanes; Cyclohexanols; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Morpholines; Naphthalenes; Phenols; Receptors, Cannabinoid; Sarcoma, Experimental

2007
[Curative effects of diverse, centrally active drugs in rats poisoned with 3-methylcholanthrene (author's transl)].
    Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology, 1975, Volume: 83, Issue:3

    Topics: Animals; Apomorphine; Brain; Electroencephalography; Ephedrine; Female; Injections, Subcutaneous; Male; Methylcholanthrene; Picrotoxin; Rats; Sarcoma, Experimental; Strychnine; Time Factors

1975